248 related articles for article (PubMed ID: 28888034)
21. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
22. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
23. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure.
Barlucchi L; Leri A; Dostal DE; Fiordaliso F; Tada H; Hintze TH; Kajstura J; Nadal-Ginard B; Anversa P
Circ Res; 2001 Feb; 88(3):298-304. PubMed ID: 11179197
[TBL] [Abstract][Full Text] [Related]
24. G-Protein-Coupled Estrogen Receptor Agonist G1 Improves Diastolic Function and Attenuates Cardiac Renin-Angiotensin System Activation in Estrogen-Deficient Hypertensive Rats.
da Silva JS; Sun X; Ahmad S; Wang H; Sudo RT; Varagic J; Ferrario CM; Zapata-Sudo G; Groban L
J Cardiovasc Pharmacol; 2019 Nov; 74(5):443-452. PubMed ID: 31361702
[TBL] [Abstract][Full Text] [Related]
25. Chymase-dependent angiotensin II forming systems in humans.
Urata H; Nishimura H; Ganten D
Am J Hypertens; 1996 Mar; 9(3):277-84. PubMed ID: 8695029
[TBL] [Abstract][Full Text] [Related]
26. Tissue angiotensin II system in the human heart.
Urata H; Hoffmann S; Ganten D
Eur Heart J; 1994 Dec; 15 Suppl D():68-78. PubMed ID: 7713117
[TBL] [Abstract][Full Text] [Related]
27. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
[TBL] [Abstract][Full Text] [Related]
28. Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7).
Peng WW; Hong L; Liu GY; Lin C; Zhao XL; Wang SZ; Lin L; Pan YX
Hypertens Res; 2019 Nov; 42(11):1745-1756. PubMed ID: 31273339
[TBL] [Abstract][Full Text] [Related]
29. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
Urata H; Boehm KD; Philip A; Kinoshita A; Gabrovsek J; Bumpus FM; Husain A
J Clin Invest; 1993 Apr; 91(4):1269-81. PubMed ID: 7682566
[TBL] [Abstract][Full Text] [Related]
30. [Effects of estrogen on ACE-Ang II-AT1 axis in ovariectomy and hypoxic pulmonary hypertension rats].
Yuan M; Duan Z; Sun Y; Yuan Y
Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(22):1696-700. PubMed ID: 25151897
[TBL] [Abstract][Full Text] [Related]
31. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
Urata H; Ganten D
Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures.
Gowrisankar YV; Clark MA
J Neurochem; 2016 Jul; 138(1):74-85. PubMed ID: 27085714
[TBL] [Abstract][Full Text] [Related]
34. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
35. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II formation in the human heart: an ACE or non-ACE-mediated pathway?
Kokkonen JO; Saarinen J; Kovanen PT
Ann Med; 1998 Aug; 30 Suppl 1():9-13. PubMed ID: 9800878
[TBL] [Abstract][Full Text] [Related]
37. High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes.
Singh VP; Le B; Bhat VB; Baker KM; Kumar R
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H939-48. PubMed ID: 17483239
[TBL] [Abstract][Full Text] [Related]
38. Role of chymase in blood pressure control, plasma and tissue angiotensin II, renal Haemodynamics, and excretion in
Roszkowska-Chojecka MM; Baranowska I; Gawrys O; Sadowski J; Walkowska A; Kalisz M; Litwiniuk A; Kompanowska-Jezierska E
Clin Exp Hypertens; 2021 Jul; 43(5):392-401. PubMed ID: 33687310
[No Abstract] [Full Text] [Related]
39. Transgenic study of the function of chymase in heart remodeling.
Chen LY; Li P; He Q; Jiang LQ; Cui CJ; Xu L; Liu LS
J Hypertens; 2002 Oct; 20(10):2047-55. PubMed ID: 12359984
[TBL] [Abstract][Full Text] [Related]
40. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.
Wei CC; Meng QC; Palmer R; Hageman GR; Durand J; Bradley WE; Farrell DM; Hankes GH; Oparil S; Dell'Italia LJ
Circulation; 1999 May; 99(19):2583-9. PubMed ID: 10330392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
